Clinical trial
Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
NCT00224445 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00224445 |
|---|---|
| Title | Boosted Atazanavir and Truvada Given Once-Daily - BATON Study |
| Official title | Boosted Atazanavir and Truvada Given Once-Daily (BATON Study): A Phase 4 Study of Safety, Efficacy & Adherence in HIV Infected, Antiretroviral Naïve Subjects Treated With a Simple Once-Daily Regimen |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Truvada, Atazanavir, Ritonavir |
| Enrollment | 100 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 23, 2005 |
| Last update posted | Jan 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: